doxorubicin

COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O
Reaction #8837
combretastatin A-4
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2006_08
Reaction #59438
MeOSuc-βAla-Leu-Ala-Leu-Dox
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2008_09
Reaction #411861
oil
Ausbeute 96.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2001_04
CC(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N1CCC[C@H]1C(=O)O.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
Reaction #969875
Fmoc-Val-Pro doxorubicin
Ausbeute 45.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2012_08
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.O=P1(N(CCCl)CCCl)NCCCO1
Reaction #991793
Cyclophosphamide Doxorubicin
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1983_12
OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
Reaction #1013868
β-Gal
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2016_03
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl
Reaction #1172417
doxorubicin hydrochloride
Ausbeute 80.3%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1991_04
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
Reaction #1437784
doxorubicin
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2007_05
Reaction #1488148
solid
Ausbeute 76.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_12
Reaction #1750199
MeOSuc-βAla-Leu-Ala-Leu-Dox
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2011_10
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
Reaction #1959656
doxorubicin
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2000_08
Reaction #1980266
CuSO4.5H2O
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_08
Reaction #1980267
CuSO4.5H2O
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_08
C=C(C)C(=O)NCCCCCC(=O)NN.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
Reaction #1997587
6-(Methacryloylamino)hexanoylhydrazine Doxorubicin
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_12
COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1O
Reaction #2075144
combretastatin A-4
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2009_06
Reaction #2257259
solid
Ausbeute 76.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2015_06
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O
Reaction #2438014
GSH doxorubicin
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1989_10